Navigation Links
Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals

Japanese vaccine producer Shigeta Animal Pharmaceuticals Inc. and Indonesia's Bogor Institute of Agriculture have announced a joint venture for the production// of a bird flu vaccine for animals. The company to be called IPB Shigeta Animal Pharmaceuticals Inc will begin the production of the vaccine in a very short time.

U.S.-based MedImmune Inc has given the green signal to the company to use its patented reverse genetics technology to manufacture the vaccine, according to Yoshiyuki Nishio, the company's president. He added that the vaccine will be used in 44 countries including Indonesia and Japan. The Bogor factory will manufacture up to 1 million doses a month, while they were building another factory capable of manufacturing 100 million doses per month. "IPB Shigeta will be able to supply vaccine to countries throughout Asia and even the rest of the world if the new factory in Indonesia becomes operational," Nishio said. Around 20 people have already succumbed to bird flu in Indonesia and the country has culled thousands of chickens and other poultry animals in a bid to control bird flu. According to the World Health Organization, 96 people have so far fallen a victim to the H5N1 strain of bird flu virus in seven countries including Cambodia, China, Indonesia, Iraq, Thailand, Vietnam and Turkey.
'"/>




Page: 1

Related medicine news :

1. New Treatment For Hip Joints
2. Joint replacement surgery outcomes may be affected by obesity and diabetes
3. New combined therapy for Knee Joint pain
4. New Hereditary Bone Joint Disorder Identified
5. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
6. A Joint Venture by Golfers And Military Forces To Combat AIDS
7. Asian Nations To Take Joint Efforts Against H5N1
8. Increase in the Demand for Artificial Joints
9. Joint Effort among Various Nations to Tackle Bird Flu
10. Joint Research by IIT-K and GSVM
11. Expect Aching Muscles And Joints This Sports Season
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: